Lesley Russell

Lesley Russell is currently an Independent Non-Executive Director at Imugene Ltd. since 2019, an Independent Non-Executive Director at Enanta Pharmaceuticals, Inc. since 2016, a Director at Melmark, Inc. since 2013, an Independent Non-Executive Director at Chimeric Therapeutics Ltd. (Australia) since 2020, and a Member of The Royal College of Physicians since 1987.
Former roles include Independent Director at Endocyte, Inc. from 2013 to 2018, Independent Director at AMAG Pharmaceuticals, Inc. from 2009 to 2019, Director-Clinical Research at USB Pharma Ltd., Medical Director at Amgen Ltd. in 1995, Director at Sojournix, Inc., Independent Director at Endocyte Pharmaceuticals, Inc., Director at Scopus Biopharma, Inc. from 2020 to 2021, Chief Medical Officer & Executive Vice President at Cephalon, Inc. from 2006 to 2011, Vice President-Clinical Research at MedImmune LLC from 1996 to 2000, Vice President-Clinical Research at U.S.
Bioscience, Inc. from 1996 to 1999, Chief Operating Officer & Chief Medical Officer at TetraLogic Pharmaceuticals Corp.
from 2013 to 2016, Senior Vice President, Head-Research & Development at Teva Pharmaceuticals USA, Inc. from 2011 to 2012, and Chief Medical Officer at Innocoll Biotherapeutics Holdings Ltd. from 2016 to 2017.
Education includes an undergraduate degree from The University of Edinburgh, conferred in 1985.